logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
L

Lin Wang

郑州大学
H指数:32
被引数:2,933

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Case Report: Safety analysis of blinatumomab consolidation therapy in two cases of acute B-cell lymphoblastic leukemia in complete remission complicated with immune effector cell-associated neurotoxicity syndrome

病例报告：blinatumomab巩固治疗在完全缓解并伴有免疫效应细胞相关神经毒性综合征的两例急性B细胞淋巴瘤白血病中的安全性分析

Frontiers in Oncology
IF3.3
2026-02-231
OAAI
Ma, Yixuan; Chang, Luyang; Mi, Ruihua; Wang, Lin; Chen, Lin; Wei, Xudong
Pharmacokinetics and bioequivalence assessment of two prucalopride formulations in healthy Chinese women: a randomized, open-label, two-period, two-sequence, self-crossover study

两种普芦卡必利制剂在健康中国女性中的药代动力学和生物等效性评价：一项随机、开放标签、两周期、两序列、自身交叉研究

FRONTIERS IN PHARMACOLOGY
IF4.8
2025-04-230
OA
Huang, Xiangxin; Wang, Ying; Li, Bei; Shen, Xiaoqun; Tao, Xuexia; Zheng, Wenwen; Luo, Qi; Xiong, Lei; Wang, Lin; Cai, Shufan
Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm open-label, multicentre, phase 2 trial
LANCET RESPIRATORY MEDICINE
IF32.8
2024-03-0119
PRE
Wang, Mengzhao; Fan, Yun; Sun, Meili; Wang, Yongsheng; Zhao, Yanqiu; Jin, Bo; Hu, Ying; Han, Zhigang; Song, Xia; Liu, Anwen; Tang, Kejing; Ding, Cuimin; Liang, Li; Wu, Lin; Gao, Junzhen; Wang, Jianghong; Cheng, Ying; Zhou, Jianying; He, Yong; Dong, Xiaorong; Yao, Yu; Yu, Yan; Wang, Huijie; Sun, Si; Huang, Jianan; Fang, Jian; Li, Wen; Wang, Lin; Ren, Xiubao; Zhou, Chengzhi; Hu, Yanping; Zhao, Dahai; Yang, Runxiang; Xu, Fei; Huang, Yijiang; Pan, Yueyin; Cui, Jiuwei; Xu, Yan; Yang, Zhenfan; Shi, Yuankai
Efficacy and Safety of Programmed Death-1 (PD-1)/Programmed Death-Ligand 1 (PD-L1) Checkpoint Inhibitors in Patients With Metastatic Castration-resistant Prostate Cancer: A Systematic Review and Meta-analysis

程序性死亡-1 (PD-1)/程序性死亡-配体-1 (PD-L1) 检查点抑制剂在转移性去势抵抗性前列腺癌患者中的疗效和安全性: 系统评价和Meta分析

CLINICAL ONCOLOGY
IF3
2024-01-010
PRE
Hong, X.; Zhang, Y.; Chi, Z.; Xu, Q.; Lin, W.; Huang, Y.; Lin, T.; Zhang, Y.
Harnessing enhanced CRISPR/Cas12a trans-cleavage activity with extended reporters and reductants for early diagnosis of Helicobacter pylori, the causative agent of peptic ulcers and stomach cancer
BIOSENSORS & BIOELECTRONICS
IF10.5
2023-02-0117
PRE
Habimana, Jean de Dieu; Mukama, Omar; Chen, Guiquan; Chen, Mengjun; Amissah, Obed Boadi; Wang, Lin; Liu, Yujie; Sun, Yirong; Li, Amy L.; Deng, Sihao; Huang, Jufang; Yan, Xiao-xin; Rutaganda, Theobard; Mutangana, Dieudonne; Wu, Lin-Ping; Huang, Rongqi; Li, Zhiyuan

研究方向

暂未获取到该数据
江
江铭虎
H 指数:18论文数:165被引数:1,522
J
Juxiang Huang
H 指数:16论文数:42被引数:522
Z
Zhenfu Jiang
H 指数:8论文数:29被引数:180
陈庆春 封面图
陈庆春
H 指数:25论文数:205被引数:2,767
Y
Yangming Wang
H 指数:32论文数:126被引数:6,108
Y
Yixiang Wang
H 指数:32论文数:229被引数:3,169
W
Wei Mao
H 指数:20论文数:137被引数:1,427
Y
Yinfei Pu
H 指数:11论文数:26被引数:257
H
Haitao Feng
H 指数:8论文数:24被引数:371
C
Chuanbin Guo
H 指数:26论文数:191被引数:2,301